Doxorubicin is the active ingredient in an antineoplastic drug commercially known as Adriblastine RD.
This injectable drug is indicated for the treatment of various cancers because it works by altering cellular function, preventing the proliferation of malignant cells.
- Head cancer; bladder cancer stomach cancer breast cancer ovarian cancer; neck cancer prostate cancer brain cancer acute lymphocytic leukemia; acute myelocytic leukemia; lymphoma neuroblastoma; sarcoma; Wilms’ tumor.
One vial of 10 mg doxorubicin costs about 92 reais
Nausea; Vomiting inflammation of the mouth Severe blood problem Severe cellulite and peeling of the skin (necrotized areas) due to excess medication; complete hair loss for 3 to 4 weeks.
Risk of pregnancy Risk C; Breastfeeding melosupression (pre-existing); impaired cardiac function prior treatment with full cumulative doses of doxorubicin; daunorrubicin and/or epirrubicin.
Injectable use
adults
Children